Results 171 to 180 of about 9,021,030 (297)

Positive Selection Targeted Primate Genes that Encode Transposable Element Repressors. [PDF]

open access: yesGenome Biol Evol
Cagliani R   +6 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Positive and Purifying Selection

open access: yes, 2019
Positive vs. Purifying Selection. A mutation that affects the function of a gene (i.e. not neutral) can change the shape and function of the product (here the product is a protein, but it could also be an RNA) or the expression pattern of the product. If
Rivera, Ajna S
core  

Gene presence-absence and evolutionary signals of positive selection associated with virulence divergence in <i>Beauveria</i> fungi. [PDF]

open access: yesMicrob Genom
Kijpornyongpan T   +5 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Proteasome alteration between epithelial and hematopoietic cells facilitates positive selection of CD8 T cells. [PDF]

open access: yesNat Commun
Matsuda-Lennikov M   +14 more
europepmc   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Detecting Interspecific Positive Selection Using Convolutional Neural Networks. [PDF]

open access: yesMol Biol Evol
West C   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy